| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Net loss | -20,953 | -22,016 | -20,217 | -18,492 |
| Net loss per share, basic (in dollars per share) | -0.99 | -1.05 | -1.19 | -1.09 |
| Net loss per share, diluted (in dollars per share) | -0.99 | -1.05 | -1.19 | -1.09 |
| Weighted-average shares of common stock outstanding, basic (in shares) | 21,168,431 | 21,055,378 | 16,953,443 | 16,941,524 |
| Weighted-average shares of common stock outstanding, diluted (in shares) | 21,168,431 | 21,055,378 | 16,953,443 | 16,941,524 |
Neurogene Inc. (NGNE)
Neurogene Inc. (NGNE)